Mammography is the current first-line imaging technique for early breast cancer detection, however, its diagnostic accuracy is limited in women with dense breast tissue. Ultrasound is often performed as a second line test in women with dense breast tissue.
Stanford researchers have developed an improved method of distinguishing live and dead cells using mass cytometry, a next-generation form of flow cytometry.
Running chemotherapeutic drug screens on tumor biopsies ex vivo has the potential to increase patient survival by personally matching them to the drug which is the most effective against their particular tumor.
Researchers at Stanford have developed a simplified LC-MS/MS metabolomics analysis method that requires only a single injection to analyze both polar and non-polar molecules with high resolution of isomeric compounds.
Engineers in Prof. Amin Arababian's laboratory have developed a microfluidics system for ultra high-throughput, low-cost, label-free cell detection in liquid biopsies, fetal cell analysis and other applications.
A team of Stanford engineers has developed an efficient battery that can convert salinity gradient power (a.k.a. “blue energy”) into electricity using low-cost, non-toxic electrode materials.
Summary: Stanford researchers at the Melosh Lab have proposed a non-invasive, high electrode density, high resolution (100 micrometers to 10 nanometers) neural device implantation for electrical stimulation of neural/biological tissues.
Stanford researchers have developed a method of assigning a “glucotype” to patients based on their temporal glycemic patterns. This algorithm classifies people with glycemic dysregulation through constant monitoring.
Researchers in Prof. Sylvia Plevritis' laboratory have developed an algorithm designed to optimize cancer combination therapy for individual patients by analyzing distinct single-cell responses from heterogeneous tumors.
Stanford researchers have designed a method to increase the photoyield of thin film CsBr/metal photocathodes by activation with electron bombardment, allowing efficient operation at UV and longer incident light wavelengths.
Stanford researchers have invented a fully water-soluble, orange hydrazine sensor that can robustly quantify the toxin hydrazine in liquids such as drinking water, waste water (treated and untreated), and bodily fluids.
Stanford researchers developed a single plasmid reprogramming system called CoMiP carrying codon optimized sequences of the canonical reprogramming factors (OKSM) and short hairpin RNA against p53.
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
Stanford researchers in the Blau Lab have discovered that telomere length can be used as a biomarker for cardiomyopathy diagnosis and drug screening with cardiomyocytes.